Extracorporeal membrane oxygenation (ECMO) is a critical intervention for patients with severe respiratory or cardiac failure, requiring careful management of anticoagulation to prevent thromboembolic complications. This review examines current practices and challenges in ECMO anticoagulation, focusing on strategies, agents, and emerging insights. Unfractionated heparin (UFH) remains the most commonly used anticoagulant, monitored via activated partial thromboplastin time (aPTT) or activated clotting time (ACT). Increasing attention is given to alternative tools like anti-Xa and viscoelastic assays (VEA), which offer potentially more reliable results. Supplementation with antithrombin should be considered if levels fall below 50%-70% to optimize heparin efficacy. Low molecular weight heparin (LMWH) is occasionally used due to its predictable pharmacokinetics, though challenges in dosing and reversal limit its application. Direct thrombin inhibitors, such as bivalirudin, are valuable alternatives, particularly for patients with heparin-induced thrombocytopenia (HIT), though their cost and availability remain barriers. Anticoagulation in ECMO patients is complex, balancing the risks of thrombosis and bleeding. Factors such as patient age, underlying conditions, and ECMO-induced coagulopathies complicate management. Personalized anticoagulation protocols and point-of-care VEA are emerging as effective tools for improving therapy. Routine no-anticoagulation strategies are not recommended unless there are significant bleeding complications. Ongoing research into novel anticoagulants and the long-term impact of anticoagulation on ECMO outcomes is critical. Anticoagulation management in ECMO continues to evolve, focusing on individualized approaches, improved monitoring, and better outcomes. Standardized protocols and further research are essential for optimizing care in this high-risk population.

Department of Anaesthesiology Resuscitation and Intensive Care Medicine 2nd Faculty of Medicine Charles University and Motol University Hospital Czech Republic

Department of Pathology and Laboratory Medicine Cedars Sinai Medical Center Los Angeles CA

Zobrazit více v PubMed

McMichael A.B.V., Ryerson L.M., Ratano D., Fan E., Faraoni D., Annich G.M. 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J Am Soc Artif Intern Organs 1992. 2022;68(3):303–310. doi: 10.1097/MAT.0000000000001652. PubMed DOI

Helms J., Frere C., Thiele T., et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023;21(2):373–396. doi: 10.1016/j.jtha.2022.11.014. PubMed DOI

Durila M., Vajter J., Garaj M., et al. Intravenous enoxaparin guided by anti-Xa in venovenous extracorporeal membrane oxygenation: a retrospective, single-center study. Artif Organs. 2024 doi: 10.1111/aor.14879. Published online October 3. Published online October 3. PubMed DOI

F. Burša J. Máca J. Sagan et al. A safety comparison of heparin and argatroban anticoa gulation in veno-venous extracorporeal membrane oxygenation with a focus on bleeding Transfus Med 2024 doi: 10.1111/tme.13102. PubMed PMC

Desai S.R., Hwang N.C. 2023 ISHLT Guidelines for Mechanical Circulatory Support. J Cardiothorac Vasc Anesth. 2023;37(12):2419–2422. doi: 10.1053/j.jvca.2023.07.044. PubMed DOI

Lorusso R., Whitman G., Milojevic M., et al. 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2021;59(1):12–53. doi: 10.1093/ejcts/ezaa283. PubMed DOI

Hartwig M., Van Berkel V., Bharat A., et al. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: the use of mechanical circulatory support in lung transplantation. J Thorac Cardiovasc Surg. 2023;165(1):301–326. doi: 10.1016/j.jtcvs.2022.06.024. PubMed DOI

Vajter J., Holubova G., Novysedlak R., et al. Anaesthesiologic considerations for Intraoperative ECMO anticoagulation during lung transplantation: a single-centre, retrospective, observational study. Transpl Int. 2024;37 doi: 10.3389/ti.2024.12752. PubMed DOI PMC

Durila M., Vajter J., Garaj M., et al. Rotational thromboelastometry reduces blood loss and blood product usage after lung transplantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2021;40(7):631–641. doi: 10.1016/j.healun.2021.03.020. PubMed DOI

Rajsic S., Breitkopf R., Treml B., et al. Association of anti-factor Xa-guided anticoagulation with hemorrhage during ECMO support: a systematic review and meta-analysis. Clin Cardiol. 2024;47(5) doi: 10.1002/clc.24273. PubMed DOI PMC

Marczin N., Waal E.E.C. de, Hopkins P.M.A., et al. International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant. 2021;40(11):1327–1348. doi: 10.1016/j.healun.2021.07.012. PubMed DOI

Martin A.K., Mercier O., Fritz A.V., et al. ISHLT consensus statement on the perioperative use of ECLS in lung transplantation: part II: intraoperative considerations. J Heart Lung Transplant. October 2024 doi: 10.1016/j.healun.2024.08.027. (Published online) PubMed DOI

Bernhardt A.M., Copeland H., Deswal A., et al. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on acute mechanical circulatory support. J Card Fail. 2023;29(3):304–374. doi: 10.1016/j.cardfail.2022.11.003. PubMed DOI

Halawi H., Sabawi M.M., Rizk E., et al. Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity. J Thromb Thrombolysis. 2024 doi: 10.1007/s11239-024-03048-0. Published online October 5. Published online October 5. PubMed DOI

Willems A., Roeleveld P.P., Labarinas S., et al. Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis. Perfusion. 2021;36(5):501–512. doi: 10.1177/0267659120952982. PubMed DOI PMC

Terry K., Lonardo N., Tonna J. Anticoagulation levels and bleeding after emergency department extracorporeal cardiopulmonary resuscitation. Curr Emerg Hosp Med Rep. 2019;7(1):1–5. doi: 10.1007/s40138-019-00176-3. DOI

Panigada M., Cucino A., Spinelli E., et al. A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation. Crit Care Med. 2020;48(11):1636–1644. doi: 10.1097/CCM.0000000000004590. PubMed DOI

Panigada M., E. Iapichino G., Brioni M., et al. Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care. 2018;8(1):7. doi: 10.1186/s13613-017-0352-8. PubMed DOI PMC

Kaseer H., Soto-Arenall M., Sanghavi D., et al. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. J Card Surg. 2020;35(4):779–786. doi: 10.1111/jocs.14458. PubMed DOI

Oude Lansink-Hartgring A., de Vries A.J., Droogh J.M., van den Bergh W.M. Hemorrhagic complications during extracorporeal membrane oxygenation - The role of anticoagulation and platelets. J Crit Care. 2019;54:239–243. doi: 10.1016/j.jcrc.2019.09.013. PubMed DOI

Buchtele N., Schörgenhofer C., Schwameis M., et al. Add-On prostaglandin E1 in venovenous extracorporeal membrane oxygenation: a randomized, double-blind, placebo-controlled pilot trial. Am J Respir Crit Care Med. 2022;206(2):170–177. doi: 10.1164/rccm.202110-2359OC. PubMed DOI

Piwowarczyk P., Borys M., Kutnik P., et al. Unfractionated heparin versus subcutaneous nadroparin in adults supported with venovenous extracorporeal membrane oxygenation: a retrospective, multicenter study. ASAIO J Am Soc Artif Intern Organs 1992. 2021;67(1):104–111. doi: 10.1097/MAT.0000000000001166. PubMed DOI

Guo Z., Sun L., Li B., et al. Anticoagulation management in severe coronavirus disease 2019 patients on extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2021;35(2):389–397. doi: 10.1053/j.jvca.2020.08.067. PubMed DOI PMC

Seeliger B., Döbler M., Friedrich R., et al. Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure. Crit Care. 2021;24(1):701. doi: 10.1186/s13054-020-03348-w. PubMed DOI PMC

Giani M., Russotto V., Pozzi M., et al. Thromboelastometry, thromboelastography, and conventional tests to assess anticoagulation during extracorporeal support: a prospective observational study. ASAIO J Am Soc Artif Intern Organs 1992. 2021;67(2):196–200. doi: 10.1097/MAT.0000000000001196. PubMed DOI

Aubron C., McQuilten Z., Bailey M., et al. Low-dose versus therapeutic anticoagulation in patients on extracorporeal membrane oxygenation: a pilot randomized trial. Crit Care Med. 2019;47(7):e563–e571. doi: 10.1097/CCM.0000000000003780. PubMed DOI

Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study. Scientific Reports. 2024 〈https://www.nature.com/articles/s41598-021-87026-z〉 Accessed November 24. Accessed November 24. Accessed November 24. PubMed PMC

Rivosecchi R.M., Arakelians A.R., Ryan J., et al. Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: heparin versus bivalirudin. Crit Care Med. 2021;49(7):1129–1136. doi: 10.1097/CCM.0000000000004944. PubMed DOI

Walker E.A., Roberts A.J., Louie E.L., Dager W.E. Bivalirudin dosing requirements in adult patients on extracorporeal life support with or without continuous renal replacement therapy. ASAIO J Am Soc Artif Intern Organs 1992. 2019;65(2):134–138. doi: 10.1097/MAT.0000000000000780. PubMed DOI

Nagler B., Staudinger T., Schellongowski P., et al. Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis. J Thromb Haemost JTH. 2024;22(10):2773–2783. doi: 10.1016/j.jtha.2024.06.008. PubMed DOI

Falter F., MacDonald S., Matthews C., Kemna E., Cañameres J., Besser M. Evaluation of point-of-care ACT coagulometers and anti-Xa activity during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2020;34(11):2921–2927. doi: 10.1053/j.jvca.2020.06.027. PubMed DOI

Thompson T.Z., Kunak R.L., Savage N.M., Agarwal S., Chazelle J., Singh G. Intraoperative monitoring of heparin: comparison of activated coagulation time and whole blood heparin measurements by different point-of-care devices with heparin concentration by laboratory-performed plasma anti-Xa assay. Lab Med. 2019;50(4):348–356. doi: 10.1093/labmed/lmz014. PubMed DOI

Marasco S.F., Lukas G., McDonald M., McMillan J., Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008;17(4):S41–47. doi: 10.1016/j.hlc.2008.08.009. PubMed DOI

Bembea M.M., Annich G., Rycus P., Oldenburg G., Berkowitz I., Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(2):e77–84. doi: 10.1097/PCC.0b013e31827127e4. PubMed DOI PMC

Laine A., Niemi T., Suojaranta-Ylinen R., et al. Decreased maximum clot firmness in rotational thromboelastometry (ROTEM®) is associated with bleeding during extracorporeal mechanical circulatory support. Perfusion. 2016;31(8):625–633. doi: 10.1177/0267659116647473. PubMed DOI

Chandel A., Desai M., King C.S., et al. Agreement between the TEG 6s and TEG 5000 analyzers in extracorporeal membrane oxygenation. ASAIO J Am Soc Artif Intern Organs 1992. 2022;68(1):73–78. doi: 10.1097/MAT.0000000000001398. PubMed DOI

Cartwright B., Bruce H.M., Kershaw G., et al. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study. Sci Rep. 2021;11(1):7975. doi: 10.1038/s41598-021-87026-z. PubMed DOI PMC

Colman E., Yin E.B., Laine G., et al. Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature. J Thorac Dis. 2019;11(8):3325–3335. doi: 10.21037/jtd.2019.08.44. PubMed DOI PMC

Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial | Trials | Full Text. Accessed November 24, 2024. https://trialsjournal.biomedcentral.com/articles/〈10.1186/s13063–022-06367-w〉. PubMed DOI PMC

Volod O., Wegner J. Viscoelastic testing in the management of adult patients on mechanical circulatory support devices with focus on extracorporeal membrane oxygenation. Semin Thromb Hemost. 2022;48:814–827. doi: 10.1055/s-0042-1756303. PubMed DOI

Volod O., Bunch C.M., Zackariya N., et al. Viscoelastic hemostatic assays: a primer on legacy and new generation devices. J Clin Med. 2022;11(3):860. doi: 10.3390/jcm11030860. PubMed DOI PMC

Mudannayake R., Lwin T., Falter F., Miles L. The HEPDOSE pilot study: the use of the PRODOSE algorithm to reverse the effects of the administration of initial high dose unfractionated heparin. J Cardiothorac Vasc Anesth. 2023;37:2. doi: 10.1053/j.jvca.2023.08.014. DOI

Schaden E., Schober A., Hacker S., Spiss C., Chiari A., Kozek-Langenecker S. Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis. 2010;21(3):256–261. doi: 10.1097/MBC.0b013e328337014c. PubMed DOI

Yin E.B., Bracey A.W., Chatterjee S. Thromboelastography versus thromboelastometry for unfractionated heparin monitoring in adult patients on extracorporeal membrane oxygenation. Perfusion. 2024 doi: 10.1177/02676591241232513. Published online February 20. PubMed DOI PMC

Rodrigues A.B., Rodrigues A., Correia C.J., Jesus G.N., Ribeiro J.M. Anticoagulation management in V-V ECMO patients: a multidisciplinary pragmatic protocol. J Clin Med. 2024;13(3):719. doi: 10.3390/jcm13030719. PubMed DOI PMC

Rajsic S., Breitkopf R., Jadzic D., Popovic Krneta M., Tauber H., Treml B. Anticoagulation strategies during extracorporeal membrane oxygenation: a narrative review. J Clin Med. 2022;11(17):5147. doi: 10.3390/jcm11175147. PubMed DOI PMC

Schaden E., Schober A., Hacker S., Spiss C., Chiari A., Kozek-Langenecker S. Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis Int J Haemost Thromb. 2010;21(3):256–261. doi: 10.1097/MBC.0b013e328337014c. PubMed DOI

Durila M., Vajter J., Garaj M., et al. Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: a pilot study. J Heart Lung Transplant. 2020;39(9):980–982. doi: 10.1016/j.healun.2020.05.015. PubMed DOI

Garaj M., Francesconi A., Durila M., Vajter J., Holubová G., Hrachovinová I. ECMO produces very rapid changes in primary hemostasis detected by PFA-200 during lung transplantation: an observational study. J Heart Lung Transplant. 2024;43(11):1771–1776. doi: 10.1016/j.healun.2024.07.012. PubMed DOI

ELSO International Summary of Statistics | ECMO | ECLS. Accessed December 5, 2024. 〈https://www.elso.org/registry/internationalsummaryandreports/internationalsummary.aspx〉.

Thomas J., Kostousov V., Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost. 2018;44(1):20–29. doi: 10.1055/s-0037-1606179. PubMed DOI

Willers A., Arens J., Mariani S., et al. New trends, advantages and disadvantages in anticoagulation and coating methods used in extracorporeal life support devices. Membranes. 2021;11(8):617. doi: 10.3390/membranes11080617. PubMed DOI PMC

Cao Y., Fang X., Ottosson J., Näslund E., Stenberg E. A comparative study of machine learning algorithms in predicting severe complications after bariatric surgery. J Clin Med. 2019;8(5):668. doi: 10.3390/jcm8050668. PubMed DOI PMC

Abbasi A., Karasu Y., Li C., Sodha N.R., Eickhoff C., Ventetuolo C.E. Machine learning to predict hemorrhage and thrombosis during extracorporeal membrane oxygenation. Crit Care. 2020;24(1):689. doi: 10.1186/s13054-020-03403-6. PubMed DOI PMC